Related Experiment Video
Updated: Sep 18, 2026

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Tuberculosis-associated immune reconstitution inflammatory syndrome in patients living with HIV-1: a 15-year
Aida Zaghdoudi1, Souhail Zayet2, Ilhem Boutiba3
1Infectious Diseases Department, University Hospital Clermont-Ferrand, Clermont-Ferrand, France.
Background:
The initiation of antiretroviral therapy in people co-infected with HIV and tuberculosis (TB) may trigger TB-associated immune reconstitution inflammatory syndrome (TB-IRIS), a condition associated with a significant morbidity and mortality.
Methods:
We conducted a retrospective study of patients co-infected with HIV and TB over 15 years, with the aim to describe the clinical characteristics of patients who developed TB-IRIS and to identify factors predictive of its occurrence.
Results:
Overall, 28 of the 123 patients (22.8%) developed TB-IRIS, including 18 cases of paradoxical TB-IRIS among 89 patients at risk (20.2%) and 10 cases of unmasking TB-IRIS among 34 patients at risk (29.4%). The most frequent TB sites were lymph nodes (n = 17, 61%), the central nervous system (CNS) (n = 5, 18%), and lungs (n = 5, 18%). Corticosteroids were administered to 9 patients (32%). Eight deaths (29%) occurred in patients with TB-IRIS. In univariate analysis, factors associated with paradoxical TB-IRIS included CNS TB (P = 0.032), higher white blood cell count (P = 0.045), and negative Toxoplasma serology (P = 0.032). Among patients at risk of unmasking TB-IRIS, factors associated with the occurrence of unmasking TB-IRIS included the absence of TB chemoprophylaxis (P = 0.017), female sex (P = 0.048), and hematopoietic-organ involvement of TB (P = 0.020).
Conclusion:
TB-IRIS is a severe complication in people living with HIV and is becoming increasingly frequent. Early identification of risk factors is essential to prevent its occurrence and to reduce associated mortality.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...